The American Society of Nephrology (ASN) is spearheading efforts to secure direct federal allocation of COVID-19 vaccines to dialysis patients and frontline dialysis workers. This allocation would improve access for a vulnerable patient population, more than half of whom are Black, Hispanic, Asian, Native American, and Native Hawaiian or other Pacific Islanders (NHPIs).
The American Society of Nephrology (ASN) is spearheading efforts to secure direct federal allocation of COVID-19 vaccines to dialysis patients and frontline dialysis workers. This allocation would improve access for a vulnerable patient population, more than half of whom are Black, Hispanic, Asian, Native American, and Native Hawaiian or other Pacific Islanders (NHPIs).
This coalition of 45 organizations is urging the Biden-Harris administration to address this public health crisis by facilitating COVID-19 vaccine allocation to all dialysis patients and frontline health workers in dialysis units.
People on dialysis need urgent access to COVID-19 vaccines
In advance of this much-needed allocation, ASN encourages the federal government to urge states to prioritize dialysis patients and staff in their vaccine allocation protocols.
COVID-19 and health equity are paramount issues affecting Americans with kidney diseases and the health professionals who care for them. Tackling these challenges will help improve the health of all Americans.
Read the full letter from the coalition. For more information about this coalition and the urgent need to deliver vaccines to kidney patients across the US, contact policy@asn-online.org.
(1) Sim JJ, et al. COVID-19 and survival in maintenance dialysis. Kidney doi: 10.1016/j. xkme.2020.11.005;